Medical Advisory Board
Aaron Weiss, DO, Associate Professor of Pediatrics, Maine Medical Center (Chair, DTRF Medical Advisory Board)
Rashmi Chugh, MD, Professor of Internal Medicine in the Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Rogel Comprehensive Cancer Center
Robert Benjamin, MD, Clinical Professor, Sarcoma, University of Texas- MD Anderson Cancer Center
Palma Dileo, MD, Consultant Medical Oncologist, London Sarcoma Service, University College London Hospitals
She completed her training at the Istituto Nazionale Tumori of Milan, Italy and at Dana-Farber Cancer Institute, Boston, USA. From 2006 to 2010 she has been Associate Physician, Medical Oncology, Istituto Nazionale Tumori, Milan working in the Sarcoma Team. She has a strong interest in early phase clinical trials and is a co-investigator for a number of clinical trials in sarcoma. She is a member of the EORTC Soft Tissue and Bone Sarcoma Group and ASCO.
Mrinal Gounder, MD, Associate Professor and Medical Oncologist, Memorial Sloan Kettering Cancer Center
Candace L. Haddox, MD, Medical Oncologist, Dana-Farber Cancer Institute
Rick Haas, MD, PhD, Division of Radiotherapy, Netherlands Cancer Institute
Rick Haas is a soft tissue sarcoma focused radiation-oncologist from the NKI-AVL in Amsterdam, the Netherlands, where he is employed now for almost 25 years. He is an active member of CTOS (Board of Directors 2015-2017), the EORTC-STBSG (President of the Local Treatment Subcommittee), and the Sarcoma Patients Euronet (SPAEN) Patient Advocacy Organization (Medical Advisory Board). He initiated several sarcoma related clinical trials in phase I (NCT01985295), phase II (NCT02575066, NCT02106312) and phase III (NCT01344018).
Peter Hohenberger, MD, PhD, Professor of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg
Bernd Kasper, MD, PhD, Professor, Mannheim University Medical Center, Interdisciplinary Tumor Center, Sarcoma Unit
Robert Lefkowitz, MD, Associate Professor, Radiology, Weill Cornell Medical College/Memorial Sloan-Kettering Cancer Center
Dr. Lefkowitz is a radiologist specializing in abdominal and musculoskeletal imaging and he has a particular interest in imaging of soft tissue tumors.
Christian Meyer, MD, PhD, Instructor of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Meyer received his bachelors and masters degrees in cell and molecular biology from Stanford University. From there, he joined the Medical Scientist Training Program at Baylor College of Medicine and earned his medical degree followed by a doctorate in immunology. Meyer completed his residency at the University of Maryland and served as chief resident in medicine from 2004-2005.
Afterward, he joined our fellowship program in medical oncology and has been working in the laboratory of Jonathan Powell, M.D., Ph.D., on projects relating to the characterization of molecular regulatory pathways involved in T-cell activation and energy. As a third-year fellow, Meyer served as the chief fellow for our Training Programs in Hematology and Medical Oncology and he received a Young Investigator Award from the American Society of Clinical Oncology in 2010.
Seth Pollack, MD. Director of the Sarcoma Program, Lurie Cancer Center, Northwestern University
His research is funded by the National Institutes of Health and the Department of Defense. He sits on the NCCN guidelines panel for soft tissue sarcomas which includes the national guidelines for desmoid tumors. During his 12 years treating patients with sarcoma at the University of Washington and Fred Hutchinson Cancer Research Center, he received the Sig Kohl Legacy award from the Northwest Sarcoma Foundation for an “outstanding and enduring contribution to the care of sarcoma patients in the Northwest.” He is thrilled to be living in Chicago and helping patients suffering from desmoid tumors at the Lurie Cancer Center.
Raphael E. Pollock, MD, PhD, Director, The Ohio State University Comprehensive Cancer Center
Ravin Ratan, MD, Associate Professor, Sarcoma, MD Anderson Cancer Center
Chandrajit P. Raut, MD, Director, Surgical Oncology, Sarcoma, Associate Professor of Surgery, Harvard Medical School
Vinod Ravi, MD, Associate Professor, Vascular Sarcomas, University of Texas MD Anderson Cancer Center
Dr. Ravi’s clinical practice is focused on vascular sarcomas such as angiosarcoma and epithelioid hemangioendothelioma. Dr. Ravi is also part of the angiosarcoma and leiomyosarcoma working groups at MD Anderson to efficiently utilize the current moonshot platforms to improve outcomes in these rare diseases. Over the course of the last 8 years that he has been at MD Anderson, he has conducted several phase II and III studies in patients with sarcoma. His clinical research interests are in the development of novel therapies for angiosarcoma and other vascular tumors.
From a data science standpoint, his research focus is utilization of multi-dimensional clinical and molecular data for identification of effective molecular therapies. Dr. Ravi is interested in correlating responses to specific targeted therapies with molecular predictors to improve clinical trial efficiency and success rates. As the clinical director of TRA (Translational Research Accelerator) program, Dr. Ravi leads the implementation of big data initiative that connects molecular data on patient samples with clinical and radiological information from electronic records.
Silvia Stacchiotti, MD, Medical Oncologist, Fondazione IRCCS Istituto Nazionale Dei Tumori
She collaborates to the Italian Network on Rare Tumors, a collaborative effort among Italian cancer centers, which tries to exploit distant patient sharing in order to improve quality of care and diminish health migration for rare solid cancers. She is a member of ESMO (European Society for Medical Oncology), Connective Tissue Oncology Society (CTOS) and of ASCO (America Society of Medical Oncology). She has authored >80 scientific publications on sarcoma.
Born in 1968, Dr. Silvia Stacchiotti received her medical degree in 1993 in Milan, and trained at the Istituto Nazionale Tumori. She is certified in Clinical Oncology.